Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics
UNCY Price/Volume Stats
Current price | $0.56 | 52-week high | $1.82 |
Prev. close | $0.53 | 52-week low | $0.20 |
Day low | $0.51 | Volume | 918,800 |
Day high | $0.56 | Avg. volume | 1,092,410 |
50-day MA | $0.67 | Dividend yield | N/A |
200-day MA | $0.58 | Market Cap | 58.13M |
UNCY Stock Price Chart Interactive Chart >
Unicycive Therapeutics, Inc., (UNCY) Company Bio
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
UNCY Price Returns
1-mo | -16.42% |
3-mo | 21.74% |
6-mo | 81.23% |
1-year | -57.25% |
3-year | -58.21% |
5-year | N/A |
YTD | -29.49% |
2024 | -8.47% |
2023 | 60.69% |
2022 | -73.79% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...